Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

SARONG Trial opens to recruitment

SARONG is a multi-centre, open-label, two-arm, parallel design, superiority Randomised Controlled Trial funded by NIHR-HTA and sponsored by the University of Oxford. The aim of the trial is to assess whether intensive surveillance after completing curatively intended treatment improves survival and health-related quality of life in patients with oesophageal or gastric cancer. We are pleased to say that SARONG is now open to recruitment, and 10 participants have been recruited in Oxford and one participant in Southampton so far (19Jul2023).

For more information or updates follow us on Twitter @SARONG_Trial and visit our website: sarong.octru.ox.ac.uk.    

Similar stories

Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient

The first patient in the UK has been recruited to a clinical trial investigating how a new drug affects liver inflammation and scarring in people with psoriatic disease using a new non-invasive MRI scanning technique.

The BALANCE study opens for recruitment - and recruits their first participant!

The SORTED study opens to recruitment!

Large UK trial shows bone healing ‘superpower’ in children

Most children with a severely broken wrist can be treated without surgery, according to a major NIHR-funded UK trial led by researchers at the University of Oxford. The findings suggest that a non-surgical, cast-first approach delivers similar long-term recovery while reducing the risks associated with surgery and costs.

WHiTE 16-DELPHIC Opens to recruitment!

Surgery unnecessary for elbow fractures in children new study finds

Researchers at NDORMS have found that surgery for a displaced medial epicondyle fracture of the elbow in children offers no clinical benefit compared to non-surgical care. The findings could have significant implications for treatment and offer huge cost savings to the NHS.